• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Jul / 2026 Right Double Right
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?

FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials

Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy

SABCS 2026 Male Breast Cancer Advocate Scholarship

Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma

First Chemotherapy Session: What to Expect

RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer

Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine

OncoCalendar

16 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
Today
  • April 2026

  • Mon 27
    p53

    20th International p53 Workshop

    Apr 27 - May 1
    SickKids Peter Gilgan Centre for Research and Learning 686 Bay St., Toronto, Ontario, Canada

    Celebrating its 20th landmark edition, the 20th International p53 Workshop arrives in Toronto from April 27 to May 1, 2026, to explore the frontier of the most frequently mutated gene […]

  • Tue 28
    Community Oncology Conference

    Community Oncology Conference 2026

    Apr 28 - Apr 29
    Walt Disney World Dolphin Resort 1500 Epcot Resorts Boulevard, Lake Buena Vista, FL, United States

    The Community Oncology Conference 2026, organized by the Community Oncology Alliance (COA), will take place on April 28–29, 2026, at the Walt Disney World Dolphin Resort in Lake Buena Vista, Florida, USA. As the leading annual event for the field, the conference's core focus is equipping community oncologists and their teams with the necessary knowledge […]

  • Tue 28
    Lung Cancer

    Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

    Apr 28 • 6:30 PM - 8:00 PM
    Virtual Event

    The Thoracic Oncology Group of Australasia (TOGA) will host the interactive webinar "Beyond the NGS Report" on Tuesday, April 28, 2026, from 6:30 pm to 8:00 pm AEDT. Specifically designed for medical oncologists practicing without immediate access to a molecular tumor board, this session provides a framework for navigating complex molecular pathology reports. Through real-world […]

  • Wed 29
    ESMO Guidelines

    ESMO Guidelines: Real World Cases – Webinar Series: Bladder Cancer 2026

    Apr 29
    Virtual Event

    The ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29, 2026, focused on translating the latest ESMO Clinical […]

  • Wed 29
    ALIGN 2026

    ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care

    Apr 29 - Apr 30
    TMC3 Collaborative Building 7255 Helix Park Ave, Houston, TX, United States

    The ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care conference is an interdisciplinary scientific meeting scheduled for April 29–30, 2026, in Houston, Texas. Organized by The University of Texas MD Anderson Cancer Center, the symposium focuses on optimizing oncological care by aligning medical treatments with individual patient values, preferences, and goals. The program […]

  • Thu 30
    Head and Neck Cancers

    How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

    Apr 30
    Virtual Event

    Closing out Head and Neck Cancers Awareness Month, the How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit addresses a disease group responsible for over 890,000 new annual diagnoses and 450,000 deaths. The program bridges the gap between emerging clinical evidence and real-world practice for early-stage, locally advanced, and recurrent/metastatic disease. The […]

  • May 2026

  • Fri 1
    Highlights of ASH

    2026 Highlights of ASH in Latin America

    May 1 - May 2
    Grand Hyatt Bogotá Cl. 24a #57 – 60, Bogota, Colombia

    The 2026 Highlights of ASH in Latin America is a two-day program scheduled for May 1–2, 2026, in Bogotá, Colombia, at the Grand Hyatt Bogotá. Organized by the American Society […]

  • Fri 1
    APPOS Washington DC

    APPOS Washington DC 2026

    May 1 - May 2
    Hyatt Regency Washington on Capitol Hill 400 New Jersey Ave NW, Washington, DC, United States

    The APPOS Washington DC 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference tailored for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, as well […]

  • Fri 1
    Cholangiocarcinoma Foundation

    Cholangiocarcinoma Foundation Annual Conference 2026

    May 1 - May 3
    Salt Palace Convention Center 90 South West Temple, Salt Lake City, UT, United States

    The 13th Cholangiocarcinoma Foundation Annual Conference, with the theme "Strength in Community: Every Patient Counts," will take place from May 1–3, 2026, in Salt Lake City, Utah. The event is hosted by the Cholangiocarcinoma Foundation and will convene a global community of leading researchers, clinicians, patients, caregivers, and advocates. Its purpose is to explore the […]

  • Sat 2
    Cancer Care and Prevention

    Cancer Care and Prevention Symposium 2026

    May 2
    The Westin Kierland Resort and Spa 6902 E Greenway Pkwy, Scottsdale, AZ, United States

    The Cancer Care and Prevention Symposium 2026, presented by Ironwood Cancer and Research Centers and Horizon CME, is a multidisciplinary conference scheduled for May 2, 2026, at The Westin Kierland Resort in Scottsdale, Arizona. The symposium is designed for a broad audience of healthcare professionals, including primary care providers and various oncologists, to discuss the […]

  • Sat 2
    ANCO

    ANCO’s Hematologic Malignancies Update 2026

    May 2 • 8:00 AM - May 3 • 12:30 PM
    Hyatt Regency Monterey Hotel And Spa 1 Old Golf Course Rd, Monterey, CA, United States

    ANCO's Hematologic Malignancies Update 2026, held May 2–3, 2026, at the Hyatt Regency Monterey, will provide clinicians, nurses, nurse practitioners, and physician assistants with the latest advances in the treatment of hematologic malignancies. The two-day meeting features expert-led sessions on clinically relevant topics to support evidence-based practice in hematology and oncology.

  • Wed 6
    ESMO Deep Dive

    ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026

    May 6
    Virtual Event

    The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6, 2026. This session focuses on the clinical management of high-risk localized prostate cancer, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji, the program features technical […]

  • Wed 6
    Cell-based Screening

    Advances in Cell-based Screening 2026

    May 6 - May 7
    AstraZeneca R&D Gothenburg Pepparedsleden 1, Mölndal, Västra Götaland, Sweden

    The 6th ELRIG Advances in Cell-based Screening 2026 is a free-to-attend, two-day scientific conference scheduled for May 6–7, 2026, in Gothenburg, Sweden. Hosted at the AstraZeneca R&D site, this interactive event brings together biologists and chemists from academia and industry to explore the latest advancements in cell-based assays. The technical program focuses on state-of-the-art screening […]

  • Wed 6
    ESMO, Abstract

    The ESMO Breast Cancer 2026

    May 6 • 8:00 AM - May 8 • 5:00 PM
    Messe Berlin Messedamm 22, Berlin, Germany

    Join the global breast cancer community at ESMO Breast Cancer 2026, taking place from 6 to 8 May 2026 in Berlin, Germany, or online. This international congress will gather top experts, researchers, and clinicians to explore the latest advances in breast cancer care, covering everything from early detection to innovative treatments and survivorship strategies. The […]

  • Wed 6
    Next-Generation Therapies

    Unlocking Next-Generation Therapies

    May 6 • 10:00 AM - 2:00 PM
    The Ritz-Carlton, Washington, D.C. 1150 22nd St NW, Washington, DC, United States

    The public meeting, "Unlocking Next-Generation Therapies," is an event co-hosted by Friends of Cancer Research and the Parker Institute for Immunotherapy (PICI), scheduled for Wednesday, May 6, 2026, from 10:00 AM to 2:00 PM ET. Held at The Ritz-Carlton in Washington, DC, with a virtual option, the meeting will gather experts to explore innovative approaches […]

  • Wed 6
    Chronic Lymphocytic Leukemia

    NCCN Webinar Series – Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

    May 6 • 3:00 PM - 4:00 PM
    Virtual Event

    NCCN will host a specialized program titled "Optimizing Patient Outcomes - When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia" on May 6, 2026, from 3:00 PM to 4:00 PM EDT. Because conventional chemotherapy often yields poor responses in Richter transformation (RT), this session focuses on the critical […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer ASCO cancer care fight against cancer Global fight against cancer Lung cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center cancer awareness colorectal cancer clinical trials Research prostate cancer Childhood Cancer FDA UICC AACR ASCO24 Dana-Farber Cancer Institute chemotherapy Pancreatic Cancer American Cancer Society radiation oncology Robert Orlowski SIOP European Cancer Organisation American Society of Clinical Oncology AI Myeloma Paper of the Day Paolo Tarantino NCI National Cancer Institute WHO Myeloma Vivek Subbiah cervical cancer radiotherapy IASLC bladder cancer Memorial Sloan Kettering Cancer Center multiple myeloma healthcare

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}